Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) Return on Sales (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Return on Sales for 3 consecutive years, with 34.67% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 1431.0% to 34.67% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 14.4% through Dec 2025, up 6485.0% year-over-year, with the annual reading at 14.46% for FY2025, 6498.0% up from the prior year.
  • Return on Sales hit 34.67% in Q4 2025 for Camp4 Therapeutics, down from 16.64% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 8.4% in Q2 2025 to a low of 141.71% in Q2 2024.
  • Historically, Return on Sales has averaged 38.54% across 3 years, with a median of 20.37% in 2024.
  • Biggest YoY gain for Return on Sales was 13331bps in 2025; the steepest drop was -1431bps in 2025.
  • Year by year, Return on Sales stood at 33.42% in 2023, then surged by 39bps to 20.37% in 2024, then plummeted by -70bps to 34.67% in 2025.
  • Business Quant data shows Return on Sales for CAMP at 34.67% in Q4 2025, 16.64% in Q3 2025, and 8.4% in Q2 2025.